Highlights and Quick Summary
- Annual 3Y Revenue Growth (per Share) for 2022 was 30.55% (a -132.18% decrease from previous year)
- Annual 3Y Revenue Growth (per Share) for 2022 was -94.93% (a 353.78% increase from previous year)
- Annual 3Y Revenue Growth (per Share) for 2021 was -20.92% (a -77.61% decrease from previous year)
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical 3Y Revenue Growth (per Share) of Benitec Biopharma Limited
Most recent 3Y Revenue Growth (per Share)of BNTC including historical data for past 10 years.Interactive Chart of 3Y Revenue Growth (per Share) of Benitec Biopharma Limited
Benitec Biopharma Limited 3Y Revenue Growth (per Share) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | – | 30.55% |
| 2021 | – | – | – | – | -20.92% |
| 2020 | – | – | – | – | 71.9% |
| 2019 | – | – | – | – | 389.22% |
| 2018 | – | – | – | – | 2251.55% |
| 2017 | – | – | – | – | 0.0% |
| 2016 | – | – | – | – | 14.13% |
| 2015 | – | – | – | – | 2210.89% |
| 2014 | – | – | – | – | -12.38% |
| 2013 | – | – | – | – | 0.0% |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology